{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T19:10:32Z","timestamp":1668021032478},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1992,11,1]],"date-time":"1992-11-01T00:00:00Z","timestamp":720576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1992,11]]},"DOI":"10.1007\/bf01703951","type":"journal-article","created":{"date-parts":[[2005,6,12]],"date-time":"2005-06-12T01:13:17Z","timestamp":1118538797000},"page":"232-235","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of neutropenia in Felty's syndrome with granulocyte-macrophage colony-stimulating factor \u2014 hematological response accompanied by pulmonary complications with lethal outcome"],"prefix":"10.1007","volume":"65","author":[{"given":"A. -R.","family":"Gari-Bai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rochlitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Riewald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Huhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01703951_CR1","first-page":"149","volume":"76","author":"IE Addison","year":"1989","unstructured":"Addison IE, Johnson B, Deverreux S, et al. (1989) GM-CSF may inhibit neutrophil migration in vivo. Clin Exp Immunol 76: 149\u2013153","journal-title":"Clin Exp Immunol"},{"key":"BF01703951_CR2","first-page":"387","volume":"63","author":"KH Antman","year":"1990","unstructured":"Antman KH (1990) G-CSF and GM-CSF in clinical trials. Yale J Biol Med 63: 387\u2013410","journal-title":"Yale J Biol Med"},{"key":"BF01703951_CR3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF01714907","volume":"62","author":"M Arning","year":"1991","unstructured":"Arning M, Klicle KO, Schneider W (1991) GM-CSF therapy and capillary leak syndrome. Ann Hemat 62: 83","journal-title":"Ann Hemat"},{"key":"BF01703951_CR4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood.V73.4.1033.1033","volume":"73","author":"GC Baldwin","year":"1989","unstructured":"Baldwin GC, Gasson JC, Kaufmann SE, et al. (1989) Non-hematopoietic tumor cells express functional M-CSF receptors. Blood 73: 1033","journal-title":"Blood"},{"key":"BF01703951_CR5","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/0277-5379(90)90613-X","volume":"26","author":"B Biesma","year":"1990","unstructured":"Biesma B, Varies EGE de, Willemse PHB, et al. (1990) Efficacy and tolerability of recombinant human GM-CSF in patients with chemotherapy-related leukopenia and fever. Eur J Cancer 26: 932\u2013936","journal-title":"Eur J Cancer"},{"key":"BF01703951_CR6","first-page":"131","volume":"9","author":"JS Cebon","year":"1990","unstructured":"Cebon JS, Morstyn G (1990) The potential role of GM-CSF in cancer chemotherapy. Cancer Surv 9: 131\u2013155","journal-title":"Cancer Surv"},{"key":"BF01703951_CR7","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1182\/blood.V73.3.694.694","volume":"73","author":"RE Champlin","year":"1989","unstructured":"Champlin RE, Nimer SD, Ireland P, et al. (1989) Treatment of refractory aplastic anemia with recombinant human GM-CSF. Blood 73: 694\u2013699","journal-title":"Blood"},{"key":"BF01703951_CR8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF01744134","volume":"61","author":"W Emminger","year":"1990","unstructured":"Emminger W, Emminger-Schmidmeier W, Peters C, et al. (1990) Capillary leak syndrome during low-dose GM-CSF treatment of a patient in a continuous febrile state. Blut 61: 219\u2013221","journal-title":"Blut"},{"issue":"Suppl 3","key":"BF01703951_CR9","first-page":"1","volume":"27","author":"DW Golde","year":"1990","unstructured":"Golde DW (1990) Overview of myeloid growth factors. Semin Hematol 27 [Suppl 3]: 1\u20137","journal-title":"Semin Hematol"},{"key":"BF01703951_CR10","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1182\/blood.V74.8.2769.2769","volume":"74","author":"BPC Hazenberg","year":"1989","unstructured":"Hazenberg BPC, Van Leeuwen MA, Van Rijswijk MH, et al. (1989) Correction of granulocytopenia in Felty's syndrome by GM-CSF. Simultaneous induction of interleukin-6 release and flare up of the rheumatoid arthritis. Blood 74: 2769\u20132773","journal-title":"Blood"},{"key":"BF01703951_CR11","first-page":"33","volume":"13","author":"K Hoffken","year":"1990","unstructured":"Hoffken K, Overkamp F, Stirbu J, et al. (1990) recombinant human GM-CSF and low-dose cytosine-arabinoside in the treatment of patients with myelodysplastic syndromes. A phase-II study Onkologie 13: 33\u201337","journal-title":"A phase-II study Onkologie"},{"key":"BF01703951_CR12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajh.2830370114","volume":"37","author":"G Joseph","year":"1991","unstructured":"Joseph G, Neustadt DH, Hamm J, et al. (1991) GM-CSF in the treatment of Felty's syndrome. Am J Hematol 37: 55\u201356","journal-title":"Am J Hematol"},{"key":"BF01703951_CR13","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/bmj.301.6764.1312-a","volume":"301","author":"RS Kaczmarski","year":"1990","unstructured":"Kaczmarski RS, Mufti GJ (1990) Hypoalbuminaemia after prolonged treatment with recombinant granulocyte-macrophage colony-stimulating factor. Br Med J 301: 1312\u20131313","journal-title":"Br Med J"},{"key":"BF01703951_CR14","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1182\/blood.V74.8.2634.2634","volume":"74","author":"G Lieschke","year":"1989","unstructured":"Lieschke G, Cebon J, Morstyn G (1989) Characterization of the clinical effects after the first dose of GM-CSF. Blood 74: 2634\u20132643","journal-title":"Blood"},{"key":"BF01703951_CR15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF01738554","volume":"61","author":"AS Lubbe","year":"1990","unstructured":"Lubbe AS, Schwella N, Riess H, et al. (1990) Improvement of pneumonia and arthritis in Felty's syndrome by treatment with GM-CSF. Blut 61: 379\u2013380","journal-title":"Blut"},{"key":"BF01703951_CR16","first-page":"1865","volume":"3","author":"HM Markusse","year":"1990","unstructured":"Markusse HM, Breedveld FC, Fibbe WE, et al. (1990) GM-CSF treatment of neutropenia associated with Felty's syndrome. Arthritis Rheum 3: 1865\u20131867","journal-title":"Arthritis Rheum"},{"key":"BF01703951_CR17","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM199106203242504","volume":"324","author":"J Nemunaitis","year":"1991","unstructured":"Nemunaitis J, Rabinowe S, Singer J, et al. (1991) Recombinant GM-CSF after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med 324: 1773\u20131778","journal-title":"N Engl J Med"},{"key":"BF01703951_CR18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood.V74.1.26.26","volume":"74","author":"N Philips","year":"1989","unstructured":"Philips N, Jacobs S, Stoller R, et al. (1989) Effect of recombinant human GM-CSF on myelopoiesis in patient with refractory metastatic carcinoma. Blood 74: 26\u201334","journal-title":"Blood"},{"key":"BF01703951_CR19","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/0140-6736(90)93111-2","volume":"336","author":"R Powles","year":"1990","unstructured":"Powles R, Smith C, Milan S, et al. (1990) Human recombinant GM-CSF in allogenic bone marrow transplantation for leukaemia: double-blind placebo-controlled trial. Lancet 336: 1417\u20131420","journal-title":"Lancet"},{"key":"BF01703951_CR20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000441-199009000-00007","volume":"300","author":"BE Robinson","year":"1990","unstructured":"Robinson BE, Quesenberry PJ (1990) Hemopoietic growth factors: overview and clinical applications, part I. Am J Med Sci 300: 163\u2013170","journal-title":"Am J Med Sci"},{"key":"BF01703951_CR21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00000441-199010000-00008","volume":"300","author":"BE Robinson","year":"1990","unstructured":"Robinson BE, Quesenberry PJ (1990) Hemopoietic growth factors: overview and clinical applications, part II. Am J Med Sci 300: 237\u2013244","journal-title":"Am J Med Sci"},{"key":"BF01703951_CR22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00000441-199011000-00008","volume":"300","author":"BE Robinson","year":"1990","unstructured":"Robinson BE, Quesenberry PJ (1990) Hemopoietic growth factors: overview and clinical applications, part III. Am J Med Sci 300: 311\u2013321","journal-title":"Am J Med Sci"},{"key":"BF01703951_CR23","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1182\/blood.V72.4.1368.1368","volume":"72","author":"SD Sisson","year":"1988","unstructured":"Sisson SD, Dinarello CA (1988) Production of interleukin-1B and tumor necrosis factor by human mononuclear cells stimulated with GM-CSF. Blood 72: 1368\u20131374","journal-title":"Blood"},{"key":"BF01703951_CR24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/bjc.1989.28","volume":"59","author":"WP Steward","year":"1989","unstructured":"Steward WP, Scarfee JH, Austin R, et al. (1989) recombinant human GM-CSF given as daily short infusions. A phase-I dose-toxicity study. Br J Cancer 59: 142\u2013145","journal-title":"Br J Cancer"},{"key":"BF01703951_CR25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0305-7372(90)90077-S","volume":"17","author":"WP Steward","year":"1990","unstructured":"Steward WP, Thatcher N, Kaye SB (1990) Clinical applications of myeloid colony-stimulating factors. Cancer Treat Rev 17: 77\u201378","journal-title":"Cancer Treat Rev"},{"key":"BF01703951_CR26","first-page":"857","volume":"51","author":"MJ Thomassen","year":"1991","unstructured":"Thomassen MJ, Muzaffar A, Barna BP, et al. (1991) Induction of cytokine in RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving GM-CSF therapy. Cancer Res 51: 857\u2013862","journal-title":"Cancer Res"},{"key":"BF01703951_CR27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1200\/JCO.1989.7.5.629","volume":"7","author":"JA Thompson","year":"1989","unstructured":"Thompson JA, Lee DJ, Kidd P, et al. (1989) Subcutanous GM-CSF in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects. J Clin Oncol 7: 629\u2013637","journal-title":"J Clin Oncol"},{"key":"BF01703951_CR28","first-page":"116","volume":"51","author":"EGE Varies de","year":"1991","unstructured":"Varies EGE de, Biesma B, Willemse PHB, et al. (1991) A double-blind chemotherapy for ovarian carcinoma. Cancer Res 51: 116\u2013122","journal-title":"Cancer Res"},{"key":"BF01703951_CR29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ajh.2830360413","volume":"36","author":"G Verhoef","year":"1991","unstructured":"Verhoef G, Boogaerts M (1991) Treatment with GM-CSF and adult respiratory distress syndrome. Am J Hematol 36: 285\u2013287","journal-title":"Am J Hematol"},{"key":"BF01703951_CR30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/0003-4819-110-4-297","volume":"110","author":"RH Weisbart","year":"1989","unstructured":"Weisbart RH, Gasson JC, Golde DW (1989) Colony-stimulating factors and host defence. Ann Intern Med 110: 297\u2013303","journal-title":"Ann Intern Med"},{"key":"BF01703951_CR31","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood.V73.3.643.643","volume":"73","author":"EJ Wing","year":"1989","unstructured":"Wing EJ, Mitchell-Magee D, Whiteside TL, et al. (1989) Recombinant human GM-CSF enhances monocyte cytotoxicity and secretion of human necrosis factor-a and interferon in cancer patients. Blood 73: 643\u2013646","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01703951.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01703951\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01703951","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T17:16:19Z","timestamp":1586279779000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01703951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,11]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1992,11]]}},"alternative-id":["BF01703951"],"URL":"https:\/\/doi.org\/10.1007\/bf01703951","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,11]]}}}